Strides Pharma Science Limited
UkraineAll drugs from this manufacturer
-
The drug is used in combination with other medicinal products for the treatment of adult patients with chronic hepatitis C.
Dosage form: tablets, film-coated
Active substance Dosage sofosbuvir 400 mg ATC: J05AP08
-
The drug is intended for the treatment of adult patients with chronic hepatitis C (CHC).
Dosage form: tablets, film-coated
Active substance Dosage ledipasvir 90 mg sofosbuvir 400 mg ATC: J05AP51
-
The drug is intended for the treatment of influenza, as well as for its prevention (after contact with an infected person or during a seasonal epidemic) in adults and children aged 1 year and older.
Dosage form: capsules
Active substance Dosage oseltamivir 75 mg ATC: J05AH02
-
The drug is used for the treatment of HIV-1 infection (in combination with other agents) and chronic hepatitis B in adults and adolescents aged 12 years and older.
Dosage form: tablets, film-coated
Active substance Dosage tenofovir disoproxil fumarate 300 mg ATC: J05AF07
-
The drug is used for the treatment of HIV-1 infection (in combination with other drugs) and chronic hepatitis B in adults and adolescents (from 12 to 18 years old).
Dosage form: tablets, film-coated
Active substance Dosage tenofovir disoproxil fumarate 300 mg ATC: J05AF07
-
It is indicated for the treatment of adult patients with chronic hepatitis C (CHC).
Dosage form: tablets, film-coated
Active substance Dosage ledipasvir 90 mg sofosbuvir 400 mg ATC: J05AP51
-
The drug is used in combination with other medicinal products for the treatment of adult patients with chronic hepatitis C (HCV).
Dosage form: tablets, film-coated
Active substance Dosage sofosbuvir 400 mg ATC: J05AP08